ION356

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ION356, covering 2025-12-12 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD) [Phase 1]

See pricing